BCMA chimeric antigen receptors
US10646558B2 · kind B2 · utility
18Cited by
29References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 8, 2019 |
| Grant date | May 12, 2020 |
| Priority date | — |
| Expiry date | Jul 8, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.